Options
Cost Effectiveness and Resource Allocation Volume 21
ISSN
14787547
Date Issued
2023
Abstract
(Methodology and results of cost-effectiveness of LDL-C lowering with evolocumab in patients with acute myocardial infarction in China - https://doi.org/10.1186/s12962-023-00501-4) -
(A systematic literature review on direct and indirect costs of triple-negative breast cancer - https://doi.org/10.1186/s12962-023-00503-2) -
(Cost-effectiveness of abemaciclib plus endocrine therapy in high-risk HR+/HER2–early breast cancer in China - https://doi.org/10.1186/s12962-023-00499-9) -
(Health system productivity in sub-Saharan Africa: tuberculosis control in high burden countries - https://doi.org/10.1186/s12962-023-00485-1) -
(Factor associated with willingness to pay for prevention of cancer: a study of prostate cancer screening - https://doi.org/10.1186/s12962-023-00494-0)
(A systematic literature review on direct and indirect costs of triple-negative breast cancer - https://doi.org/10.1186/s12962-023-00503-2) -
(Cost-effectiveness of abemaciclib plus endocrine therapy in high-risk HR+/HER2–early breast cancer in China - https://doi.org/10.1186/s12962-023-00499-9) -
(Health system productivity in sub-Saharan Africa: tuberculosis control in high burden countries - https://doi.org/10.1186/s12962-023-00485-1) -
(Factor associated with willingness to pay for prevention of cancer: a study of prostate cancer screening - https://doi.org/10.1186/s12962-023-00494-0)
File(s)